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AgingAge-associated decline in antioxidant potential and accumulation of reactive oxygen/nitrogen species are primary
causes for multiple health problems, including muscular dystrophy and sarcopenia. The role of the nuclear
erythroid-2-p45-related factor-2 (Nrf2) signaling has been implicated in antioxidant gene regulation. Here, we
investigated the loss-of-function mechanisms for age-dependent regulation of Nrf2/ARE (Antioxidant Response
Element) signaling in skeletal muscle (SM). Under basal physiological conditions, disruption of Nrf2 showed
minimal effects on antioxidant defenses in young (2 months) Nrf2−/− mice. Interestingly, mRNA and protein
levels of NADH Quinone Oxidase-1 were dramatically (*Pb0.001) decreased in Nrf2−/− SM when compared
to WT at 2 months of age, suggesting central regulation of NQO1 occurs through Nrf2. Subsequent analysis of
the Nrf2-dependent transcription and translation showed that the aged mice (>24 months) had a signiﬁcant
increase in ROS along with a decrease in glutathione (GSH) levels and impaired antioxidants in Nrf2−/− when
compared to WT SM. Further, disruption of Nrf2 appears to induce oxidative stress (increased ROS, HNE-
positive proteins), ubiquitination and pro-apoptotic signals in the aged SM of Nrf2−/−mice. These results indi-
cate a direct role for Nrf2/ARE signaling on impairment of antioxidants, which contribute to muscle degradation
pathways upon aging. Our ﬁndings conclude that though the loss of Nrf2 is not amenable at younger age; it could
severely affect the SMdefenses upon aging. Thus, Nrf2 signalingmight be a potential therapeutic target to protect
the SM from age-dependent accumulation of ROS by rescuing redox homeostasis to prevent age-related muscle
disorders such as sarcopenia and myopathy.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
An increase in the aged population is a major public health
concern in the United States and across theworld aswell [1–3]. Age-de-
pendent decrease in antioxidant mechanisms and profound accumula-
tion of reactive oxygen/nitrogen species (ROS/RNS) are causally linked
to various health problems, such as muscular dystrophy, sarcopenia,
cancer, diabetes, cardiovascular and neurodegenerative diseases [4–8].
Major myocyte and muscular disorders in the elderly such as skeletaledicine Building, Divisions of
ine, University of Utah Health
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l rights reserved.muscle weakness, sarcopenia, muscular dystrophy, and myopathy are
ascribed to increased oxidative stress [9–15], but the underlyingmolec-
ular mechanisms remain poorly deﬁned.
Transcription factors that regulate antioxidant genes have been
recently studied in humans and mouse models of disease [16–18].
One such factor, known as Nrf2, is regarded as a master regulator of
antioxidant transcription [16,19–23]. Nrf2 binds to the antioxidant
response element (ARE) in the promoter of target antioxidant genes
and tightly regulates its transcription [24]. Though numerous studies
have demonstrated a key role for Nrf2 in various disease models
[17,22,25–30], its primary function in the context of aging skeletal
muscle remains poorly understood. A recent study has reported a sig-
niﬁcant decrease ofNrf2 nuclear expression in elderly humanswho lead
a less-physically active lifestyle [31], while physically active humans
exhibited improved Nrf2 function. Another study in rats has shown
that aging is associated with impaired hepatic Nrf2 levels and GSH
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down-regulation of gene and protein levels for GCLC and GCLM, sub-
units of GCL, the rate limiting enzyme for biosynthesis of GSH [32].
Kensler et al. [33] have observed similarities between older wild-type
and Nrf2−/− mice suggesting age-dependent impairment of Nrf2-
ARE signaling. However, the role of Nrf2/ARE signaling within the
context of aging has not been investigated in the skeletal muscle.
Glutathione (GSH) is a ubiquitous small molecular thiol antioxi-
dant whose biosynthesis is tightly controlled by its rate limiting en-
zyme γ-glutamyl cysteine ligase (γGCL), which is transcriptionally
regulated by Nrf2 [34–36]. Abrogation or deﬁciency of Nrf2 is impli-
cated in the impairment of GSH production and thereby alters the in-
tracellular redox state [16,17,34,36]. In general, young animal and
human SM tissues exhibit a homeostatic redox state by maintaining
a balance between oxidants and antioxidants. On the other hand, ex-
cess production and accumulation of ROS in an aged condition leads
to chronic pathological complications including loss of healthy myo-
cytes, accumulation of oxidized proteins/lipids, DNA damage, etc.
Skeletal muscle myocytes are enriched with mitochondria (accounts
for 1/3 of the total weight of myocytes), which are one of the primary
sources for ROS generation and therefore increase the susceptibility
to age-dependent oxidative damage.
Aging promotes ROS/RNS accumulation in various tissues includ-
ing skeletal muscle (SM), which contributes to chronic oxidativeFig. 1. Protein levels for Nrf2 and Keap1 in mice skeletal muscle (SM). Western blots showin
SM. (C) Immunoﬂuorescence analysis using anti-Nrf2-ab in SM sections from WT and Nrf2−
analysis (hematoxylin staining) of SM from young and old WT/Nrf2−/− mice. Myocytes fro
mice, myocytes from old had reduced size when compared to young mice. Data are mean±stress and muscle disorders [37–42]. Recent studies have observed
that aging results in impaired function of Nrf2 in human skeletal mus-
cle, vascular endothelial/smooth muscle cells of non-human primate
(Macaca mulatta) and rat kidney [31,43,44]. We hypothesize that
Nrf2-deﬁciency will lead to deregulation of skeletal muscle cytopro-
tective mechanisms upon age-induced oxidative stress. In this
study, our primary goals are to investigate whether the Nrf2 pathway
is an essential component of SM redox homeostasis and to assess
whether there is age-dependent regulation of Nrf2/ARE-driven anti-
oxidant signaling in SM. Understanding the molecular mechanisms
for muscular dysfunction and pathology, that are linked with aging,
will enhance our ability to design potential therapeutic strategies
aimed at reversing age-related complications. Using age matched
(~2 and >24 month old) WT and Nrf2−/− mice, we investigated
the mechanisms for antioxidant regulation and cell degeneration in
the skeletal muscle.
2. Materials and methods
2.1. Animals
Nrf2−/− mice were originally generated by Itoh et al. [20]. We
obtained the Nrf2-deﬁcient (Nrf2−/−) mice with a hybrid background
from Dr. Li Wang (University of Utah, Salt Lake City, UT). Theyg protein expression for Nrf2 (A) and Keap1 (B) in 2 months old WT and Nrf2−/−mice
/− mice conﬁrmed Nrf2 expression in WT and abrogation in the KO. (D) Histological
m Nrf2−/−mice were relatively smaller than that of WT at both ages. Within the WT
SD for n=4–6/group. *Pb0.001.
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laboratory. Nrf2−/− (knockout) male mice and their littermate con-
trols,Nrf2+/+ (wild-type) used in this studywere obtained from inter-
crossing Nrf2+/− (heterogenous) mice. The mice were genotyped for
Nrf2 expression by PCR ampliﬁcation of genomic DNA using the follow-
ing primers: Nrf2 forward: 5-GCCTGAGAGCTGTAGGCCC-3, Nrf2
reverse: 5-GGAATGGAAAATAGCTCCTGCC-3, Nrf2 mutant: 5-GGGTT-
TTCCCAGTCACGAC-3. WT and Nrf2−/−mice were housed under con-
trolled temperature, humidity and a 12-hour light/dark cycle. They
were fed with a standard rodent diet and water ad libitum. At indicated
time points (2 and>24 months of age), agematchedWT and Nrf2−/−
male mice were sacriﬁced and the skeletal muscle was isolated. All
experimental protocols conducted on the mice were approved by
IACUC at the University of Utah in accordancewith the standards estab-
lished by the U.S. Animal Welfare Act.
2.2. Antibodies and reagents
We have used the following antibodies and reagents: Nrf2-ab (SC-
722, Santa Cruz Bio, SC, USA), Keap-1 (10503-2-AP, Proteantech,
Chicago, USA), NQO-1 (ab34173), GAPDH (ab9485), lamin-B1
(ab16048), Catalase (219010, Calbiochem, Merck GaA, Germany),Fig. 2. Effect of Nrf2 and age on ROS levels determined by electron paramagnetic resonance
(spin-trap) to form adducts with ROS (superoxide and hydroxide) and measured in EPR. In
when compared to WT in young mice (A-B). The ROS levels were signiﬁcantly (Pb0.015) in
for n=4–6/group. C. Detection of ROS using redox sensitive ﬂuorescent probes: Sections fr
DCFH-DA (hydroperoxides) and DHE (superoxide) were imaged using confocal microscopy
Data indicate similar trend in the ROS levels as shown in EPR results. When compared to y
gesting age-dependent increase. At both ages, Nrf2−/− SM had signiﬁcantly increased ROSγ-GCS (RB-1697-P1, Labvision/Neomarkers, CA, USA), SOD-1 (Enzo-
CAD-SOD-100), caspase-3, caspase-9 (Cell Signaling Tech-9662/
9504) and ubiquitin-ab (Enzo-BML-PW0150). Secondary antibodies
conjugated with horseradish peroxidase IgG (Rabbit and Mouse/PI-
1000 and PI-2000, Vector labs, Burlingame, USA) were used. Radical
detecting EPR probes—CMH (NOX-2.1), TEMPOL (705748, Sigma-
Aldrich, St. Louis, MO, USA), EPR grade water (NOX-7.7.1), Krebs-
HEPES buffer (NOX-7.6.1), DETC (NOX-10.1), DF (NOX-9.1), glass
capillary tubes (NOX-G.3.1) and critoseal (NOX-A. 3.1-VP) were pur-
chased from Noxygen Diagnostics, Germany. Bio-Rad Protein Assay
(500-0006, Bio-Rad, Hercules, CA) was used to determine protein
levels in skeletal muscle tissue extracts. All reagents and primers for
RNA extraction and real-time RT-PCR quantiﬁcation were purchased
from Qiagen Inc., Valencia, CA.
2.3. Preparation of tissues/samples for analysis
Young (2 months) and old (>24 months) wild type (WT) and
Nrf2−/− mice (n=6–8/group) were sacriﬁced. The skeletal muscle
was then excised and processed/frozen for subsequent analysis
[45,46]. For EPR analysis, 10 mg portions of muscle were immediately
washed and processed in EPR buffer and analyzed soon after. For(EPR) spectroscopy. SM tissues were processed in EPR buffer and incubated with CMH
creasing trend, but statistically non-signiﬁcant, in ROS levels observed in Nrf2−/− SM
creased in Nrf2−/− when compared to WT at >24 months of age. Data are mean±SD
om frozen SM of WT and Nrf2−/− mice at 2 and 24 months of age were treated with
and quantiﬁed by automated image analysis using the Simple PCI 6 Imaging Software.
oung, the old WT and Nrf2−/− SM showing increased DCF and DHE ﬂuorescence sug-
when compared to WT. Data are mean±SD for n=3/group. *Pb0.01.
Fig. 2 (continued).
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washed and homogenized with MES buffer. A 10 μl aliquot was
saved for protein determination and metaphosphoric acid (MPA)
extracts were stored at −80 °C until the analysis.
2.4. Histology of skeletal muscle
Histochemistry analysis was performed as described by Song et al.
Cross-sections of skeletal muscle were cut (5 μm thick) in cryostat
(−20 °C), placed on pre-coated slides, and air dried for 30 min. For
assessment of cross-sectional area, geometry, and extracellular
space, the sections were stained with 2–5 drops of hematoxylin and
incubated for 5 min at room temperature to highlight nuclei and mi-
tochondria. Stained sections were washed with PBS, air dried and
mounted with cytoseal (Richard-Allan Scientiﬁc, MI, USA).
2.5. Skeletal muscle glutathione (GSH) redox state
Redox state of glutathione (GSH/GSSG) was determined in skele-
tal muscle tissue extracts from WT and Nrf2−/− mice at 2 and
>24 months of age. Brieﬂy, skeletal muscle tissue extracts were pre-
pared in MES buffer and centrifuged at 5000 rpm for 5 min at 4 °C.
Proteins were measured using 10 μl aliquot of the supernatants and
the remaining samples were mixed with equal volumes of 10% MPA
(239275, Sigma) to precipitate proteins. TEAM (Tri-ethanolamine)
reagent was added to a known volume of the MPA extracts, followed
by 2-vinyl pyridine (for GSSG analysis). The GSSG standards were
treated similarly to prepare a standard graph. Kinetic readings for
GSH-reductase recycling assay were recorded as per the manufac-
turer's instructions (703002, Cayman Chemicals, Ann Arbor, USA)
using a plate reader (Bio-Tek, FLx-800) [30,47,48].2.6. Electron Paramagnetic Resonance (EPR) spectroscopy-based ROS
determination
To assess the effect of Nrf2-deﬁciency and aging on ROS formation,
we measured the CMH (spin trap) signals in young and old SM tissues
using EPR. In brief, mice were injected (intraperitoneally) with hepa-
rin (4 U/g b.w.) and sacriﬁced by CO2 inhalation. A portion of the SM
was cut into small pieces, placed in a clean 24-well culture plate con-
taining 500 μL HEPES (20 μM, pH 7.4), washed twice, and immersed
in 300 μL of HEPES buffer. Ten milligrams of processed SM tissue
was incubated with 200 μL of 500 μM CMH (1-hydroxy-3-methoxy-
carbonyl-2, 2,5,5-tetramethyl pyrrolidine) at 37 °C for 30 min in a
CO2 incubator. The ROS released by the SM reacts with CMH and
forms a stable nitroxide radical, which can be measured using EPR.
After 30 min of incubation, 50 μl of the reaction mixture was mea-
sured in a glass capillary using an EMX-ESR spectrometer (Bruker In-
struments, Germany) as reported previously [30,49].
2.7. Detection of ROS using ﬂuorescent probes (DCFDA/DHE)
Generation of superoxide and peroxides in the SM of young
(2 months) and old (>24months) mice was determined using DHE/
H2DCFDA (D11347/C6827, Invitrogen Corp. USA) ﬂuorescence by follow-
ing our previous report [30]. The cell-permeable non-ﬂuorescent DHE is
oxidized to ﬂuorescent 2-hydroxyethidium, which is then detected by
using the excitation/emission ﬁlters appropriate for rhodamine. In the
presence of superoxide (O2−∙), oxidized ethidium intercalates with DNA,
staining the nucleus a bright red ﬂuorescence. Hydrogen peroxide
oxidizes H2DCFDA to a ﬂuorescent DCF which can be detected by a ﬂuo-
rescentmicroscope using appropriate excitation/emission ﬁlters for ﬂuo-
rescence as reported previously [50]. Brieﬂy, 5-μm-thick transverse
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(SM) tissues on clean glass slides were appropriately covered with the
probe solution containing DHE/H2DCFDA (10 μM) and were incubated
in a light-protected chamber at 37 °C for 30 min and washed thoroughly
with 1× PBS thrice, ﬁxed and mounted using DAPI containing Vector-
Flouromount-G. Fluorescent images of the DCF and DHE were obtained
using a FV-1000 laser scanning confocalmicroscope (Olympus Inc.). Fluo-
rescence intensity was quantiﬁed by automated image analysis using the
Simple PCI 6 Imaging Software (Hamamatsu Corporation, Sewickley, PA).
2.8. Skeletal muscle tissue homogenization and immunoblotting
Skeletal muscles were harvested from 2 and >24 months old WT
and Nrf2−/− animals and ﬂash frozen in liquid nitrogen [30]. Cyto-
solic fractions from the SM were prepared by homogenizing the tis-
sue using cytosolic buffer (10 mM HEPES, 10 mM KCl, 0.1 mM EDTA,
0.5 mM MgCl2, with freshly prepared 1 mM dithiothreitol, 0.1 mM
phenyl methylsulfonyl ﬂuoride (PMSF) and 1% Triton-X100, pH 7.9),
followed by centrifugation at 5000 rpm for 5–6 min. The nuclear
pellet was washed with 4 volumes of homogenizing buffer to remove
cytosolic contaminants. Nuclear proteins were prepared in nuclear
extraction buffer (NEB; 20 mM HEPES, 420 mM NaCl, 0.1 mM EDTA,
1.5 mM MgCl2, 25% glycerol and 1 mM dithiothreitol, 0.5 mM PMSF,
pH 7.9). Samples in the NEB were incubated on ice with mild shaking
and centrifuged at 8200 rpm for 10 min. Then the proteins were
quantiﬁed using Bradford reagent (Bio-rad). Protein samples for
Western blots were prepared in 4× Laemmli buffer with 5% freshlyFig. 3. RNA levels for SM from young and old WT/Nrf2−/− mice. Quantitative PCR
analyses were performed using respective cDNA and Qiagen primer sets. (A) Gene
expression for young mice- the RNA levels for Gcs, G6pd, Sod1 were unaltered
between the WT and Nrf2−/−, but Nqo1 and Gsr were dramatically downregulated
in Nrf2−/−. Catalase RNA was higher in the Nrf2−/− when compare to WT.
(B) Gene expression for old mice—the RNA levels for most of the antioxidants
(Gcs, G6pd, Sod1 and Gsr) except catalase were signiﬁcantly down regulated in the
Nrf2−/− when compared to WT at 24 months of age. The changes in the transcript
levels reﬂect on the respective protein expression. The mRNA expression for catalase
was down regulated signiﬁcantly (Pb0.05) in Nrf2−/− when compare to WT at 2
and 24 months of age. Data are mean±SD for n=4–6/group. *Pb0.05; **Pb0.01.added β-mercapto-ethanol and boiled for 5 min. Thirty micrograms
of cytosolic proteins were separated on 10 or 12% SDS-PAGE and
transferred to PVDF membranes. The membranes were treated with
appropriate antibodies such as Nrf2, Keap1, catalase, SOD-1, GSR,
G6PD, NQO-1, ubiquitin, γ-GCS, caspase-3/9, GAPDH and lamin-B1.
Horseradish peroxidase IgG (rabbit and mouse) conjugated second-
ary antibodies were used for chemiluminescence detection of protein
signals.2.9. Gene expression analysis by quantitative real time PCR
Skeletal muscle tissues were harvested and washed with RNase
free PBS and stored in RNAlater reagent. RNA was extracted from
~20 mg of SM tissue of 2 and 24 month old WT and Nrf2−/− mice
(N=4–6) using RNA extraction kits (Qiagen #74106), following
the manufacturer's instructions. The quantity and quality of the
RNA was analyzed using a bioanalyzer. To synthesize cDNA, the re-
verse transcription reaction was performed on 2.5 μg of RNA using a
Qiagen Reverse Transcription Kit (205311) as per manufacturer's in-
structions. For qPCR analysis, 100 ng of cDNA template, 10 μL of
SYBR green master mix (Qiagen-204054) and respective Qiagen
primer sets for NQO-1 (QT00094367), catalase (QT01058106), G6PD
(QT00120750), GCLC (QT QT00130543), Nrf2 (QT00095270), Sod-1
(QT01762719) and Gsr (QT01758232) were used and analyzed in a
Roche-Light Cycler. Quantiﬁcation of copy numbers of cDNA targets
were performed using Ct values. Fold changes for respective gene ex-
pression were calculated by normalizing to the level of the house-
keeping gene Arbp1 (QT00249375) or GAPDH (QT01658692).Fig. 4. Antioxidant protein expression for young mice: Western blots showing protein
expression for antioxidant enzymes in WT and Nrf2−/− mice at 2 months of age.
Abrogation of Nrf2 does not affect on the levels of catalase, G6PD, SOD1, SOD2 and
GSR, but NQO1 protein levels were signiﬁcantly decreased (>5 fold down regulation)
in Nrf2−/− when compared to age matched WT mice. Immunoblots of GCS showed
a minimal (10%) increase in Nrf2−/− when compared to WT, indicating the presence
of Nrf2 independent mechanisms for its regulation. Data are mean±SD for n=4–6/
group. *Pb0.05; **Pb0.01.
Fig. 5. Antioxidant protein proﬁle for old mice: Western blots showing protein expres-
sion for antioxidant enzymes in WT and Nrf2−/− mice at 24 months of age. Abroga-
tion of Nrf2 signiﬁcantly affects the protein levels of most of the antioxidants (GCS,
catalase, G6PD, GSR and NQO1) on aging. All these proteins were dramatically de-
creased in aged-Nrf2−/− when compared to the age matched WT mice. However,
the level of SOD1 was unaltered, but the SOD2 protein was increased in Nrf2−/− on
aging. Age dependent decrease in transcript levels for antioxidants in Nrf2−/− mice
correspond well with the protein levels. Data are mean±SD for n=4–6/group.
*Pb0.05; **Pb0.01.
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Frozen skeletal muscle (OCT) sections at 5 μm thickness from the
WT and Nrf2−/−mice at 2 and 24 months old were immunostained
with respective primary antibodies as reported previously [30,47].
The SM tissue sections were primarily ﬁxed in 4.0% paraformaldehyde
for 10 min, permeabilized with 0.25% Triton X-100 in PBS containing
0.01% Tween-20 for 5 min, and blocked for 60 min with 5% goat
serum in 0.01% PBST. Incubation with the appropriate primary anti-
body diluted in 0.01% PBST containing 1% BSA was carried out over
night at 4 °C. After three (5 min each) washes with PBST, the sections
were incubated with appropriate secondary anti-mouse Alexa-Fluor
488-conjugated or anti-Rabbit Alexa-Fluor 647-conjugated anti-
bodies (1:500 dilution) for 1 hour at room temperature. After three
washes (5 min each) with 1× PBST, the sections were mounted
with DAPI containing mounting medium (Vector Shield) and imaged
using a FV-1000 Confocal (Olympus Inc.) microscope at a magniﬁca-
tion of 60× for visualization of speciﬁc localization and expression
of NEF2 (1:200), GSR (1:200), catalase (1:300), G6PD (1:150),
NQO1 (1:400), and GCS (1:200). Fluorescent intensity was quantiﬁed
by automated image analysis using the Simple PCI 6 Imaging Software
(Hamamatsu Corporation, Sewickley, PA).
2.11. Statistical analysis
All data were statistically analyzed using Student t-test and P-
values less than 0.05 were considered statistically signiﬁcant. Data
are presented as mean±standard deviation. For each parameter,
the WT was compared to a corresponding Nrf2−/− group of the re-
spective age. No comparisons were made between the young vs. old
groups.
3. Results
3.1. Nrf2 and Keap1 proteins are conserved in the mouse skeletal muscle
The Nrf2-Keap1 pathway is one of the critical regulators of intra-
cellular redox homeostasis in multiple cells and organs [33,51]. West-
ern blots from skeletal muscle (SM) homogenates conﬁrm the
expression of Nrf2 and Keap1 (Fig. 1A–B) in WT and its abrogation
in Nrf2−/−mice. Comparable expression of Keap1 protein and tran-
script (data not shown) levels were observed in the SM of WT and
Nrf2−/− mice, suggesting abrogation of Nrf2 did not inﬂuence
Keap1 protein levels. Further, immunoﬂuorescence analysis conﬁrms
Nrf2 expression in adult WT, while Nrf2−/− mice had no signals for
anti-Nrf2-ab. (Fig. 1C). Next, we performed histological analysis (he-
matoxylin staining) of frozen skeletal muscle sections from young
(2 months) and old (24 months) WT and Nrf2−/− mice (Fig. 1D).
When compared to WT, the size of the myocytes from Nrf2−/−
were smaller (30%), but there was no evidence of intercellular space
at 2 months of age. Interestingly, the old SM of WT and Nrf2−/− ex-
hibit atrophy and derangement of nuclei was noted. However, the old
Nrf2−/− SM showed an increased number of myocytes exhibiting
atrophy when compared to the age matched WT. These results indi-
cate that loss of Nrf2 might be a contributing factor for age-associated
myocyte degeneration.
3.2. Under unstressed/physiological setting, the loss of Nrf2 has minimal
effect on skeletal muscle redox state in young mice
The skeletal muscle (SM) generates relatively more ROS, through
mitochondrial activity and NADPH oxidase(s), than other tissues
[52–55]. To combat accumulation of ROS, the myocytes have evolved
with a potential defense system that includes non-protein thiols
such as glutathione and enzymatic antioxidants. To investigate
whether the loss of Nrf2 can impair GSH synthesis and induceoxidative stress in SM tissue, we measured the reduced/oxidized
forms of glutathione (GSH/GSSG) in 2 month old mice. Under basal
physiological state and younger age, GSH levels and the redox ratio
were unaltered in Nrf2−/− SM when compared with age matched
WT mice (data not shown). However, signiﬁcant (Pb0.05) decrease
in GSH content (1.0±0.08 vs. 0.6±0.1; WT vs. Nrf2−/−) and GSH/
GSSG ratio (30.5±3.05 vs.20.0±2.0; WT vs. Nrf2−/−) were
recorded in Nrf2−/− when compared to SM of WT mice at
24 months of age. These results indicate that age-associated decline
in antioxidant function is accelerated due to abrogation of Nrf2. Main-
taining a balance between antioxidant and pro-oxidant levels is
critical for the intracellular redox homeostasis. We hypothesize that
disruption of Nrf2, a master regulator of antioxidant transcription,
will impair antioxidant defense mechanisms in SM under basal set-
tings. To understand the free radical load in the SM, we performed
radical-spin trap analysis using EPR spectroscopy. The EPR signals
for CMH (superoxide+hydroxyl) were indistinguishable in the
young WT and Nrf2−/− mice (Fig. 2A–B). Upon aging, there was a
signiﬁcant increase in ROS levels of Nrf2−/− SM when compared to
age matched WT mice (Fig. 2). We further conﬁrmed the levels
of ROS using redox sensitive ﬂuorescent probes (DCFH-DA/DHE)
of WT and Nrf2−/− mice at young and old ages. The ﬂuorescence
analysis revealed increased ROS (superoxide and hydrogen peroxide)
levels in the old WT and Nrf2−/− mice when compared to young
mice, suggesting the accumulation of ROS with aging (Fig. 2C). An
accumulation of ROS along with GSH depletion was evident in the
Nrf2−/− mice SM. Thus, abrogation of Nrf2 impairs defense mecha-
nisms and promotes oxidative stress in SM upon aging. Taken
1044 C.J. Miller et al. / Biochimica et Biophysica Acta 1822 (2012) 1038–1050together, the loss of Nrf2 is not deleterious to the skeletal muscle
under basal-physiological or unstressed states.
3.3. NQO1 (but not other antioxidants) mRNA and protein expression are
decreased in young Nrf2−/− mouse SM
NAD(P)H-quinone oxidoreductase-1 (NQO1) is one of the major
phase-II antioxidant enzymes that catalyzes the 2-electron reduction
of quinones and thereby quenches toxicity [56]. To determine the
effects of Nrf2 abrogation on major antioxidant gene expression,
we performed q-PCR analysis in young (2 months of age) WT and
Nrf2−/−mice. Results showed signiﬁcant (Pb0.001) down regula-
tion of Nqo1 mRNA in Nrf2−/− when compared to WT mice SM at
both age points (Fig. 3A–B). Next, we analyzed NQO1 protein levels
by Western blotting and observed a 5 fold decrease in Nrf2−/−
when compared with age-matched WT mice (Figs. 4–5). These
results suggest that disruption of Nrf2 is necessary and sufﬁcient
to down regulate Nqo1 transcription and thereby decrease its
protein levels. Though the transcription of NQO1 is induced by
various xenobiotics, it has been recently demonstrated that Nrf2Fig. 6. Immunoﬂuorescence analyses of antioxidant enzymes. Immunoﬂuorescence analy
(1:400) and anti-GCS (1:200) antibodies showing their expression in WT and Nrf2−/−
GSR, catalase, GCS were comparable between the groups, but the NQO1 and G6PD were sig
tioxidant enzymes were signiﬁcantly decreased in Nrf2−/− when compared to age-match
(DAPI); red: antioxidant and pink: merge of blue and red indicating nuclear localization oftightly regulates Nqo1 expression. Next, we observed a moderate,
but not signiﬁcant, increase in some of the antioxidants (namely
G6PD and GCS) in Nrf2−/− when compared to WT mice at 2 months
of age. However, the transcript and protein levels for other antioxi-
dants such as catalase, GSR and SOD-1 were similar between the
WT and Nrf2−/− groups, suggesting that loss of Nrf2 has a minimal
role on antioxidant regulation/function under basal physiological
state and/or young age.
3.4. Sustained abrogation of Nrf2 down-regulates transcription of
ARE-containing antioxidant genes upon aging
We hypothesized that abrogation of Nrf2 might inhibit transcrip-
tional activation of downstream targets including critical antioxidant
pathways associated with glutathione homeostasis in the SM. To test
this hypothesis, we performed qPCR analysis using RNA isolated from
SM of 24 month old WT and Nrf2−/− mice. We selected major anti-
oxidant genes under the control of Nrf2/ARE. Expression of catalase,
G6pdx, Gsr, Gcs, Sod-1 and Nqo1 (Fig. 3B) was signiﬁcantly lower in
the Nrf2−/− compared with WT mouse SM, suggesting a lack ofsis using anti-GSR (1: 200), anti-catalase-ab (1:400), anti-G6PD (1:200), anti-NQO1
of young (A) and old (B) skeletal muscle sections. In the young mouse, the levels of
niﬁcantly decreased in Nrf2−/− when compared to the WT. Upon aging, all these an-
ed WT mice. Data are mean±SD for n=3–4/group. *Pb0.05; **Pb0.01. Blue: nucleus
Nrf2.
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2 months of age, the WT and Nrf2−/− mice had indistinguishable
levels of transcript expression for most of these genes (except Nqo1
and Gsr) (Fig. 3A), indicating that age-dependent oxidative stress
could severely compromise antioxidant mechanisms under Nrf2-
deﬁcient conditions.
3.5. Depletion of major antioxidant enzymes in the SM of Nrf2-deﬁcient
mice upon aging
To characterize whether Nrf2-deﬁciency, in part, is responsible for
the decreased GSH levels upon aging in the mouse skeletal muscle,
we measured protein expression for major targets of Nrf2 and the en-
zymes that are involved in GSH metabolism and redox homeostasis
usingWestern blots. At 2 months of age, there appeared to be compa-
rable levels of protein expression for most of the antioxidants (GCS,
CAT, SOD1, SOD2, GSR) among WT and Nrf2−/− mice (Fig.4). How-
ever, many of the antioxidants including catalase (1.0 vs. 0.15 in
old), NQO1 (1.0 vs 0.15 in old), G6PD (1.0 vs. 0.12 in old), GCS (1.0
vs. 0.25) and GSR (1.0 vs. 0.45 in old) were dramatically (Pb0.001)
decreased in the old Nrf2−/− when compared to age-matched WT
mice SM (Fig. 5). Overall, Western blot analysis revealed signiﬁcant
depletion of antioxidants (GCS, NQO1, SOD1, catalase, G6PD and
GSR) in Nrf2−/−mice, while WT mice exhibited compensatory anti-
oxidant responses to the aging changes. Further, immunoﬂuores-
cence analysis revealed identical changes in the expression ofantioxidant enzymes. Though GSR, catalase, and GCS were unaltered,
G6PD and NQO1 were signiﬁcantly decreased in the Nrf2−/− when
compared to WT mice at 2 months of age (Fig. 6A). In the aging SM,
all the antioxidants (GSR, catalase, G6PD, NQO1 and GCS) were
dramatically decreased in the Nrf2−/− when compared to age-
matched WT mice (Fig. 6B). These results conﬁrm the protein blots
(Figs. 4–5) and suggest that the effect of aging is exacerbated in the
absence of Nrf2. The observed lower antioxidant enzyme levels
could be attributed to (i) increased utilization of these antioxidants
and (ii) absence of inducible antioxidant mechanisms via Nrf2 to
combat age-associated ROS accumulation.3.6. Abrogation of Nrf2 enhances/activates apoptotic pathways in aged
mice
Apoptosis, a well known mechanism for programmed cell degra-
dation, is associated with aging. To understand possible mechanisms
linked to Nrf2-deﬁciency and subsequent oxidative stress in SM, we
analyzed key markers of apoptotic pathways. Western blots for
caspase-3 and caspase-9 indicated no changes between WT and
Nrf2−/− mice at 2 months of age (Fig. 7A). Notably, these levels
were signiﬁcantly increased in Nrf2−/− when compared to WT at
24 months of age along with other apoptotic markers (AIF, ASK1,
BAX, BAD) (Fig. 7B), suggesting prominent activation of apoptosis
due to the loss of Nrf2 and/or aging.
Fig. 7. Effect of age on Nrf2 dependent oxidative stress and apoptotic pathways. Western blots showing caspase-3, caspase-9, ASK1, AIF, BAX and BAD expression in WT and Nrf2−/−
mice SM at young and old ages. (A) Caspase-3 and 9 levels were indistinguishable between WT and Nrf2−/−mice at 2 months of age. (B) Protein expression of most of the apoptotic
markers (casp-3/9, AIF, ASK1, BAX, BAD) were signiﬁcantly increased in Nrf2−/− when compared to WT mice at 24 months of age. Activation of apoptotic pathway is evident in the
aged Nrf2−/−mice. Data are mean±SD for n=4–6/group. *Pb0.01.
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in Nrf2−/− mice
In general, degradation of oxidatively modiﬁed or misfolded pro-
teins occurs through ubiquitin-proteasome systems (UPS). Oxidative
stress promotes ubiquitin-protein conjugates and degradation of sev-
eral proteins and enzymes [57–59]. We tested whether the increased
ROS and oxidative stress would trigger protein degradation in Nrf2-
abrogated SM. Analysis of protein blots using mono- and polyclonal
anti-ubiquitin-ab revealed no difference in ubiquitin-protein conju-
gates between WT and Nrf2−/− groups at young age (data not
shown), whereas the aged Nrf2−/− SM showed a signiﬁcant increase
of ubiquitin-protein conjugates when compared to WT upon aging
(>24 months) (Fig. 8A). Next, to assess the effect of Nrf2 and aging
on lipid peroxidation, we have measured the skeletal muscle 4-HNE
(lipid peroxidation marker) content in young and old WT/Nrf2−/−
mice. There were no signiﬁcant differences observed between the
WT and Nrf2−/− at young age, but a dramatic increase in HNE-
positive proteins was seen in Nrf2−/− when compared to WT at
old age (Fig. 8B). Signiﬁcant increase in HNE-signals for a wide
range of proteins (from 10 kDa to 250 kDa) in the Nrf2−/− mouse
SMwhen compared toWT was evident. These results suggest that ab-
rogation of Nrf2 and age-associated augmentation of oxidative stress
are associated with increased ubiquitination, which in turn results in
protein degradation.4. Discussion
Our investigation has identiﬁed Nrf2 as a critical factor that has-
tens age-associated oxidative stress, ubiquitination and apoptosis in
skeletal muscles. The age-dependent effect of Nrf2 signaling in skele-
tal muscle has been only partially understood. Oxidative stress and
associated pathogenic mechanisms in aged humans received ample
attention in the context of muscular function/dysfunction (Fig. 9).
However, the Nrf2-dependent antioxidant function and protein deg-
radation/apoptosis in SM has not been previously investigated in
the context of aging. Our current ﬁndings reveal that abrogation of
Nrf2 (i) has a minimal role on SM redox state in younger age, (ii) re-
sult in myocyte atrophy with aging, (iii) impairs transcription of anti-
oxidants upon aging, (iv) increases oxidative stress and (v) activates
ubiquitination and apoptotic signals upon aging. Our results demon-
strate that abrogation of Nrf2 contributes to age-associated oxidative
stress and impairs cytoprotective mechanisms.
4.1. Disruption of Nrf2 has a minimal role on skeletal muscle antioxidant
mechanism at younger age
The majority of Nrf2 is activated upon changes in the redox state
due to ROS generation, and both toxic and electrophilic stress [60].
Coordinated regulation of Nrf2 signaling is believed to preserve the
redox state and protect skeletal muscle structure and function.
Fig. 8. Oxidative stress induced lipid peroxidation and ubiquitination in Nrf2−/− mice. (A) Western blots probed for mono-/poly-ubiquitination-ab revealing increased ubiquiti-
nation of proteins in aged Nrf2−/− mice. Densitometry analysis showing ~2 fold increase in poly-ubiquitinated proteins in aged Nrf2−/− when compared to age matched WT
mice. (B) Western blots probed for anti-HNE-ab showing comparable signals in skeletal muscles of WT and Nrf2−/− at 2 months of age. In the old mice, signiﬁcant increases of
HNE-modiﬁed proteins are evident in Nrf2−/− SM when compared to age-matched WT (n=4/group; *Pb0.01).
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the antioxidants and normal redox state in SM of age-matched WT
and Nrf2−/− groups (2 months). Hence the young mice had basal
ROS and glutathione levels; we believe that the skeletal muscle did
not develop oxidative stress despite the loss of Nrf2 in young mice.
However, the transcript and protein expression for NQO1 was
dramatically decreased in young Nrf2−/− mice (Figs. 3–5), but this
was idle on the redox state of the SM. These ﬁndings suggest that
primary regulation of NQO1 occurs through Nrf2 albeit age. Of late,
few studies have documented the role of stress-induced Nrf2 in
age-associated transcriptional regulation of defense systems against
oxidative stress. In addition, we observed comparable levels of ROS,
redox state and ubiquitination among WT and Nrf2−/− mice indi-
cating a homeostatic, basal intracellular environment at 2 months of
age. Taken together, these results provide evidence of a minimal
role for Nrf2 under basal conditions including young age.
4.2. Abrogation of Nrf2 promotes oxidative stress and impairs
antioxidant mechanisms upon aging
Increased production of reactive oxygen and nitrogen species
(ROS/RNS) results in oxidative stress, which is implicated in the
development of multiple diseases including muscular dystrophy
[38,53,61]. Previous reports have documented that the loss of Nrf2
is strongly coupled with dysregulation of antioxidant pathways and
progression of diseases [16–18]. A question addressed in this study
is whether Nrf2−/−mice are susceptible to an age-associated trigger
for ROS generation and accumulation in the skeletal muscle. Earlier
investigations show evidence that aging can induce ROS generation
through a variety of mechanisms including loss of potential radicalscavenging antioxidants [62]. Here we demonstrate that ROS was
generated in both the WT and Nrf2−/− mouse skeletal muscles
upon aging, but the magnitude of ROS accumulation was signiﬁcantly
higher in aged Nrf2−/− mice, suggesting low abundance and poor
activation of cytoprotective mechanisms. The striking decline in
several antioxidant proteins (catalase, NQO1, γ-GCS, GSR, SOD-1,
G6PD etc.) upon aging in Nrf2−/− mice might be attributed to an
increased consumption of these antioxidant enzymes and decreased
translation processes due to loss of Nrf2/ARE-dependent transcrip-
tion. Further, gene expression (real time qPCR) analysis revealed sig-
niﬁcant down-regulation of several antioxidant genes in Nrf2−/−
mice after aging, indicating an important transcriptional regulatory
role of Nrf2 in skeletal muscle antioxidant defenses. Our results sug-
gest that the loss of Nrf2 makes myocytes vulnerable to oxidative
damage. Thus, Nrf2/ARE signaling is crucial to protect the skeletal
muscle from age-dependent oxidative stress diseases.
4.3. Deregulation of antioxidants and oxidative stress induce apoptosis in
skeletal muscle of aged Nrf2−/− mice
Apoptosis is a regulated energy-dependent process of cellular
self-destruction. Activation of a cascade of cysteine proteases and
endonucleases such as caspases occurs at the onset of the apoptotic
process [63]. It has been previously shown that apoptotic events
are directly linked with cell aging [39,64–66]. Usually, aging is associ-
ated with a loss of cells in the post mitotic tissues of the brain, heart
and skeletal muscle [39,63–66]. Thus, a decline in the number of
viable, fat-free myocytes results in skeletal muscle dysfunction. We
postulated that apoptosis is one of the mechanisms involved in the
process of age-associated oxidative stress and that abrogation of
Fig. 9. Effect of Nrf2-deﬁciency and age induced oxidative stress on ubiquitination. Under basal state, majority of the Nrf2 is degraded by its repressor, Keap1. Upon induction, the
Nrf2 dissociates from Keap1 and translocates into nucleus. Abrogation of Nrf2 leads to accumulation of ROS and chronic oxidative stress during aging.
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apoptosis. In the current study, activation of apoptotic (ASK1, AIF)
and pro-apototic (BAD, BAX) signals induces downstream apoptotic
pathways (caspase-3 and 9) in aged Nrf2−/− mice due to increased
generation/accumulation of ROS/RNS and decreased reducing equiva-
lents such as glutathione (GSH). Excess generation of ROS and/or RNS
could indirectly induce apoptotic signals by altering the membrane
potential, permeability pore opening and release of cytochrome-C
from the mitochondria [67–69]. Therefore, aging and loss of Nrf2
might have hastened the apoptotic process in the skeletal muscles
of aged Nrf2−/− mice.
4.4. Loss of Nrf2 exacerbates age-associated oxidative stress and
promotes ubiquitination
Age associated oxidative stress is believed to cause a variety of
biochemical and conformational modiﬁcations in macromolecules
[40–42]. These changes, along with prolonged oxidative damage
in organelles and cells, result in dysfunction. Numerous studies
have reported that increased ROS/RNS generation and oxidative/
nitrosative stress contribute to several age-associated diseases in
humans [5,7,8,39,44,70,71]. Previous studies have shown that de-
clined Nrf2 signaling is associated with increased oxidative stress inaged sedentary humans while aged active human skeletal muscle
exhibited increased nuclear Nrf2 levels and subsequent activation
of its major target antioxidant enzymes such as HO1 and γ-GCLC
[31]. Accordingly, aged WT mice had increased ROS levels and
impaired redox capability, which was further magniﬁed in the
Nrf2−/− mice due to the loss of inducible cytoprotective mecha-
nisms. Steady state levels of phase II defense components are crucial
to scavenge oxidative/nitrosative free radicals and protect cells/or-
gans from oxidative, toxic and xenobiotic stress. In the current
study, depletion of several key antioxidant scavenging enzymes pro-
moted oxidative stress and ubiquitination in aged Nrf2−/− skeletal
muscle. Further, lipid peroxidation analyses reveal that abrogation
of Nrf2 is coupled with increased HNE-positive proteins on aging,
which might also contribute to activation of apoptotic cascades. It
has been reported that moderately high levels of 4-HNE can induce
apoptosis and leads to muscular weakness [72–74]. Therefore, a
steady state function of Nrf2 signaling is critical to preserve SM anti-
oxidant defense and redox homeostasis.
4.5. Future directions and clinical impact
Our ﬁndings show that induction of a battery of major antioxidant
genes at transcriptional and translational capacity is feasible through
1049C.J. Miller et al. / Biochimica et Biophysica Acta 1822 (2012) 1038–1050Nrf2/ARE signaling. We speculate that activation of Nrf2-dependent
pathways could be cytoprotective against a wide range of age-
associated diseases of skeletal muscle in humans. In the follow-up
studies, we intend to investigate whether pharmacological or non-
pharmacological (exercise) manipulation could promote sustained
activation of Nrf2 in aged mice. Such constitutive Nrf2 function is
expected to rescue redox homeostasis and prevent age-dependent
disorders in skeletal muscle. Future clinical investigations include
assessing the effect of chronic regimented and spontaneous exercise
(to increase adaptive response) on maintaining a steady-state func-
tion of Nrf2 and thereby achieving potential intracellular cytoprotec-
tive defense mechanisms and redox homeostasis in elderly humans.
Pharmacological based activation of Nrf2 signaling will be aimed at
patients with moving disabilities.
5. Conclusions
Abrogation of Nrf2 promotes an age-associated increase in ROS
generation and oxidative stress in skeletal muscle. Further, disruption
of Nrf2 increases ubiquitination and apoptosis upon aging. Nrf2
signaling might be a potential therapeutic target to protect the SM
from well-known muscular diseases due to ROS and oxidative stress.
Innovation: Our study provides evidence, for the ﬁrst time, that abro-
gation of Nrf2 is coupled with increased ubiquitination and apoptosis
in skeletal muscle upon aging. A constant activation/stabilization
of Nrf2 signaling might be efﬁcacious in maintaining homeostatic
redox milieu and thereby ameliorating age-associated muscular
disorders.
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